semaglutide and ibs-d Patients with stable inflammatory bowel disease (IBD) comorbid obesity and/or diabetes who started GLP-1 receptor agonists (semaglutide or tirzepatide) alongside ongoing treatment did not have a lower risk for the relapse Why Semaglutide Causes Diarrhea: Understanding

A highly cited 2020 umbrella meta-analysis of 37 randomized controlled trials concluded that L-carnitine supplementation provides a modest but significant reducing effect on body weight, body mass index (BMI), and fat mass

Anti-obesity therapy for cardiovascular disease prevention: potential expected roles of glucagon-like peptide-1 receptor agonists

Antioxidants Redox Signaling 39 (1-3), 141161

Reduced glutathione is involved in the synthesis and repair of DNA, and enhances the antioxidant activity of vitamin C, transport of amino acids, and detoxification of harmful compounds

Potential side effects may include: Certain medical conditions may increase the risk of side effects or make the glutathione treatments unsuitable, including: These topics will also be covered in your individual consultation with our medical providers before prescribing

These potential dangers have prompted the FDA to issue warnings and recommend that healthcare providers carefully monitor patients on Ozempic, particularly those with a history of pancreatic or thyroid conditions